NYSE:SOLVMedical Equipment
Assessing Solventum (SOLV) Valuation As Recent Momentum Meets Perceived Undervaluation
Solventum overview and recent performance
Solventum (SOLV) has drawn fresh attention as a standalone healthcare company, with investors weighing its recent trading performance against fundamentals such as revenue of US$8.26b and net income of US$1.43b.
See our latest analysis for Solventum.
At a share price of US$76.13, Solventum has delivered a 1-month share price return of 8.7% and a 1-year total shareholder return of 4.63%, suggesting recent momentum has improved after weaker year to date...